An Approach to Cancer Patients in the Covid-19 Pandemic Era

The aim of this article is to give an overview of an approach to cancer patients in the covid-19 pandemic. The treatment recommendations are prioritized as per the risk stratification till the current crisis is mitigated. Measures like telemedicine/telecommunication, triage system, proved to be very effective in prevention of covid contact of cancer patients. Guidelines and protocols are needed that can decrease the risks in cancer management in such pandemic times. Multi-disciplinary work and effective communication between oncology team, critical care and emergency units is the key to optimizing clinical care of cancer patients.

[1]  Arpitha S Rao,et al.  Study of effect of Corona-19 pandemic on radiation oncology practice – Single institution experience , 2021, Journal of Radiation and Cancer Research.

[2]  F. André,et al.  Abstract CT403: Outcome of cancer patients infected with COVID-19, including toxicity of cancer treatments , 2020 .

[3]  S. Başcı,et al.  The outcome of COVID‐19 in patients with hematological malignancy , 2020, Journal of medical virology.

[4]  S. Roberts,et al.  COVID‐19 disease in New York City pediatric hematology and oncology patients , 2020, Pediatric blood & cancer.

[5]  L. Madero,et al.  COVID‐19 infection in children and adolescents with cancer in Madrid , 2020, Pediatric blood & cancer.

[6]  J. Bussink,et al.  Practice recommendations for lung cancer radiotherapy during the COVID-19 pandemic: An ESTRO-ASTRO consensus statement☆ , 2020, Radiotherapy and Oncology.

[7]  A. Garden,et al.  Practice Recommendations for Risk-Adapted Head and Neck Cancer Radiation Therapy During the COVID-19 Pandemic: An ASTRO-ESTRO Consensus Statement , 2020, International Journal of Radiation Oncology*Biology*Physics.

[8]  S. Pantilat,et al.  Rapid Implementation of Inpatient Telepalliative Medicine Consultations During COVID-19 Pandemic , 2020, Journal of Pain and Symptom Management.

[9]  P. Iyengar,et al.  Practice recommendations for lung cancer radiotherapy during the COVID-19 pandemic: An ESTRO-ASTRO consensus statement , 2020, Radiotherapy and Oncology.

[10]  R. Malekzadeh,et al.  COVID19 Prevention & Care; A Cancer Specific Guideline. , 2020, Archives of Iranian medicine.

[11]  A. Desai,et al.  COVID-19 and Cancer: Lessons From a Pooled Meta-Analysis. , 2020, JCO global oncology.

[12]  C. Wang,et al.  Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China , 2020, Annals of Oncology.

[13]  M. Chua,et al.  SARS-CoV-2 Transmission in Patients With Cancer at a Tertiary Care Hospital in Wuhan, China , 2020, JAMA oncology.

[14]  Rui Ji,et al.  Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis , 2020, International Journal of Infectious Diseases.

[15]  J. Hollander,et al.  Virtually Perfect? Telemedicine for Covid-19. , 2020, The New England journal of medicine.

[16]  C. Villarreal-Garza,et al.  Provider delay in treatment initiation and its influence on survival outcomes in women with operable breast cancer. , 2020, Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology.

[17]  Zunyou Wu,et al.  Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. , 2020, JAMA.

[18]  Ruchong Chen,et al.  Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China , 2020, The Lancet Oncology.

[19]  Youn-Jung Kim,et al.  High mortality from viral pneumonia in patients with cancer , 2019, Infectious diseases.

[20]  Y. Kim,et al.  The impact of delayed commencement of adjuvant chemotherapy (eight or more weeks) on survival in stage II and III colon cancer: a national population-based cohort study. , 2017, Oncotarget.

[21]  K. Rolston.  Infections in Cancer Patients with Solid Tumors: A Review , 2017, Infectious Diseases and Therapy.

[22]  S. Giordano,et al.  Delayed Initiation of Adjuvant Chemotherapy Among Patients With Breast Cancer. , 2016, JAMA oncology.

[23]  M. V. van Oijen,et al.  Timing of adjuvant chemotherapy and its relation to survival among patients with stage III colon cancer. , 2015, European journal of cancer.

[24]  G. Hortobagyi,et al.  Clinical impact of delaying initiation of adjuvant chemotherapy in patients with breast cancer. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  Susan E. Cohen,et al.  Moving upstream: a review of the evidence of the impact of outpatient palliative care. , 2013, Journal of palliative medicine.

[26]  Lisa Barbera,et al.  Does delay in starting treatment affect the outcomes of radiotherapy? A systematic review. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[27]  ScienceDirect.  International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases. , 1996 .

[28]  S. Parlee,et al.  This Work Is Licensed under a Creative Commons Attribution-noncommercial 4.0 International License , 2022 .